Life sciences briefing: Monday, Feb. 4, 2008
TODAY’S HEADLINES:
PEAK Surgical takes in $21M for electrosurgical tools (release)
CellGate acquired by Australian cancer biotech ProGen for $2.5M (release)
Traversa raises $2M for RNAi-delivery technologies (release)
RemitDATA, Web-based healthcare-service co., takes in $5.5M (bizjournals.com)
Spinal-implant maker Archus Orthopedics gets $10M venture loan (release)
Promedior pulls down another $5.5M for fibrotic disease (release)
Acrongenomics takes 11 percent stake in Molecular Vision (release)
Hepatitis drug-developer Biolex withdraws IPO (IPO Home)
Employee drug screener eScreen gets Carlyle investment (release)
NovaMin raises $2.5M for dental-care products (VentureWire)
Cardious… Continue Reading
Life sciences briefing: Tuesday, Sept. 4, 2007
Featured companies: Berkeley HeartLab, Celera Group, the Foundry, Molecular Vision, Morgenthaler Ventures
Former genomics pioneer Celera Group buys Berkeley HealthLab for $195M — Rockville, Md.-based Celera Group, a one-time tie finisher in the race to decode the human genome, has agreed to acquire Berkeley HealthLab, a Burlingame, Calif., heart-related diagnostic company, for $195 million in cash.
Celera, once a high-flying genomics outfit, tried to reinvent itself as a drug-development company following the collapse of the “genomics bubble”… Continue Reading